Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
1.290
-0.130 (-9.15%)
At close: Nov 20, 2026, 4:00 PM EST
1.310
+0.020 (1.55%)
After-hours: Nov 20, 2026, 7:41 PM EST
Quantum BioPharma Employees
Quantum BioPharma had 17 employees as of December 31, 2022. The number of employees increased by 7 or 70.00% compared to the previous year. That makes Quantum BioPharma the 38,931st largest employer in the world and 5,634th in the United States.
Employees
17
Change (1Y)
7
Growth (1Y)
70.00%
Revenue / Employee
n/a
Profits / Employee
-$1,184,519
Market Cap
11.30M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2022 | 17 | 7 | 70.00% | 17 | 0 |
| Dec 31, 2021 | 10 | 1 | 11.11% | 10 | 0 |
| Dec 31, 2020 | 9 | -9 | -50.00% | 9 | 0 |
| Dec 31, 2019 | 18 | -1 | -5.26% | 17 | 1 |
| Sep 30, 2019 | 23 | 4 | 21.05% | 23 | 0 |
| Jun 30, 2019 | 19 | - | - | 19 | 0 |
| Dec 31, 2018 | 19 | - | - | 19 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 113 |
| Fractyl Health | 100 |
| Seres Therapeutics | 66 |
| Acumen Pharmaceuticals | 61 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| Context Therapeutics | 15 |
| NewcelX | 12 |
QNTM News
- 3 days ago - 3 Quantum Computing ETFs with 47%+ Upside Potential, According to Analysts - TipRanks
- 7 days ago - Quantum BioPharma achieve 91% increase in Shareholder Equity and Liquidity in Q3 2026 as Lucid-MS Phase 2 Trial Advances into Study Start-Up - GlobeNewsWire
- 9 days ago - Quantum BioPharma Announces Results of Annual General and Special Meeting of Shareholders and Closing of Private Placement of Class A Multiple Voting Shares - GlobeNewsWire
- 15 days ago - Quantum BioPharma Ltd. Announces Filing of Supplement to Management Information Circular Correcting Fractional Share Treatment Under Proposed Share Consolidation and Clarifies MVS Voting Power Threshold - GlobeNewsWire
- 23 days ago - 3 Quantum Computing ETFs with 30%+ Upside Potential, According to Analysts - TipRanks
- 6 weeks ago - Quantum BioPharma signs contract with Thermo Fisher for sclerosis trial - TheFly
- 6 weeks ago - Quantum BioPharma Signs Contract with Thermo Fisher Scientific's Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis - GlobeNewsWire
- 7 weeks ago - IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd. - GlobeNewsWire